Viral Vector Biosafety in Laboratory Animal Research.

about

Special Issue: Infectious Disease Research: Animal Models and Risk Management.Highly efficient siRNA transfection in macrophages using apoptotic body-mimic Ca-PS lipopolyplex

P2860

Q40153299-BB0B9C81-765B-4EB6-BECE-CC045F011771 Q58694457-8F29CC32-C9FC-47A5-8496-4F7642BC3F16

P2860

Viral Vector Biosafety in Laboratory Animal Research.

Item

http://www.wikidata.org/entity/Q39405329

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Viral Vector Biosafety in Laboratory Animal Research.

@en

Viral Vector Biosafety in Laboratory Animal Research.

@nl

type

Item

label

Viral Vector Biosafety in Laboratory Animal Research.

@en

Viral Vector Biosafety in Laboratory Animal Research.

@nl

prefLabel

Viral Vector Biosafety in Laboratory Animal Research.

@en

Viral Vector Biosafety in Laboratory Animal Research.

@nl

P1476

Viral Vector Biosafety in Laboratory Animal Research.

@en

P2093

Dalis E Collins

http://www.w3.org/2001/XMLSchema#string

Howard G Rush

http://www.w3.org/2001/XMLSchema#string

Jason S Villano

http://www.w3.org/2001/XMLSchema#string

Jon D Reuter

http://www.w3.org/2001/XMLSchema#string

P2860

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

Comparative study of inactivation of herpes simplex virus types 1 and 2 by commonly used antiseptic agents

General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

Factors in the Selection of Surface Disinfectants for Use in a Laboratory Animal Setting

A third-generation lentivirus vector with a conditional packaging system

An inventory of shedding data from clinical gene therapy trials.

Development of a self-inactivating lentivirus vector.

Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors.

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.

P304

215-221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28662750

http://www.w3.org/2001/XMLSchema#string

P932

5482513

http://www.w3.org/2001/XMLSchema#string

Viral Vector Biosafety in Laboratory Animal Research.

about

P2860

P2860

Viral Vector Biosafety in Laboratory Animal Research.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932